Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu SafiledCriticalMenarini Int Operations Lu Sa
Priority to ARP050105280priorityCriticalpatent/AR052993A1/en
Publication of AR052993A1publicationCriticalpatent/AR052993A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Formas de dosificacion oral que contienen sal cálcica zofenopril, particularmente formas de dosificacion oral solidas que contienen una combinacion de zofenopril polimorfa A sustancialmente pura de polimorfa B e hidroclorotiazida (HCTZ) y procesos para su preparacion.Oral dosage forms containing zofenopril calcium salt, particularly solid oral dosage forms containing a combination of substantially pure zofenopril polymorph A of polymorph B and hydrochlorothiazide (HCTZ) and processes for its preparation.
ARP0501052802005-12-152005-12-15
PHARMACEUTICAL COMPOSITION CONTAINING ZOFENOPRIL AND HCTZ FOR THE TREATMENT OF HYPERTENSION
AR052993A1
(en)
Compounds derived from 2-pyridinecarboxamide, glucosinase activator; pharmaceutical composition; and use of the compound for the treatment of diabetes or obesity.
COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE PI3 QUINASA ACTIVITY; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE FOR CANCER PROFILACTIC OR THERAPEUTIC TREATMENT.
PHARMACEUTICAL COMPOSITION OF SOLID DOSAGE INCLUDING VALSARTAN, AMLODIPINA, HYDROCHLOROTIAZIDA AND PHARMACEUTICALLY ACCEPTABLE ADDITIVES; PREPARATION PROCEDURE; AND USE FOR THE TREATMENT OF HYPERTENSION, CARDIAC INSUFFICIENCY, INFARTO D
Compounds n- (3- (4as, 7as) -2-amino-4a, 5,7,7a-tetrahydro-4h-furo [3,4-d] [1,3] thiazin-7a-yl) -4- fluorophenyl) -5-fluoropiconylamide, bace inhibitor; pharmaceutical composition comprising them, use of the compound for the treatment of Alzheimer's disease.
A PHARMACEUTICAL COMPOSITION THAT INCLUDES POLYMODIC FORMS OF 3- (4-AMINO-1-OXO-1.3 DYHIDRO-ISOINDOL-2-IL) -PIPERIDINA-2,6-DIONA FOR THE TREATMENT AND HANDLING OF CANCERES
COMPOUNDS DERIVED FROM NITROGEN HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
Pharmaceutical composition comprising a dpp iv inhibitor compound with an amino group or a salt thereof, a first diluent, a second diluent, a binder, a disintegrant and a lubricant, useful in the treatment of diabetes mellitus.
COMPOUNDS DERIVED FROM SUBSTITUTED BENZAMIDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF DIABETES, INTOLERANCE TO GLUCOSE, DISLIPIDEMIA, HYPERTENSION, OBESITY.
COMPOUNDS DERIVED FROM INDOL WITH UNITED RING IN POSITIONS 4,5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A VIRAL INFECTION.
COMPOUNDS DERIVED FROM MACROCICLES, INHIBITORS OF THE SERINE PROTEASE OF HEPATITIS C; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF HEPATITIS C.
Compounds derived from quinoline-carboxamide, antagonists of p2y12; preparation procedure; pharmaceutical composition comprising said compound; composition of a combination of said compounds; and use of the compound in the treatment of cardiovascular disorders, thromboembolism, acute myocardial infarction.
COMPOUNDS DERIVED FROM 2H-ISOQUINOLIN-1-ONA AND 3H-QUINAZOLIN-4-ONA, RHO KINASE INHIBITORS; AND PHARMACEUTICAL COMPOSITION, USEFUL FOR THE TREATMENT OF A CARDIOVASCULAR DISEASE OR AFFECTION.
COMPOUNDS DERIVED FROM PIRIMIDO [5,4-D] [2] BENZAZEPINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
Pharmaceutical composition comprising (1s)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-metoxy-4-methylphenyl]-1-thio-d-glucitol and metformin and uses thereof in the treatment of diabetes
Piperidine derived compounds; Pharmaceutical composition and use for the treatment and / or prophylaxis of diseases selected from hypertension, congestive heart failure and renal failure, among others.
Compounds derived from 3-benzoisoxazole-piperidine; pharmaceutical composition comprising said compounds; and its use for the treatment and / or prevention of cognitive disorders, drug addiction, depression, anxiety, among others.
Macrocyclic aminoindole derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.
Pharmaceutical composition covered by a film comprising capecitabine and at least one disintegrant, useful in the treatment of cancer for patients who have difficulty swallowing oral solid dosage forms.